| NCT00004288 |
|
Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
|
View
|
| NCT00004287 |
|
Phase I Study of the Third Generation Adenovirus H5001CBCFTR in Patients With Cystic Fibrosis
|
View
|
| NCT00004286 |
|
Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
|
View
|
| NCT00004285 |
|
Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
|
View
|
| NCT00004284 |
|
Phase III Randomized Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria
|
View
|
| NCT00004278 |
|
Phase III Randomized Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
|
View
|
| NCT00004276 |
|
Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections
|
View
|
| NCT00004275 |
|
Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turners Syndrome
|
View
|
| NCT00004274 |
|
Effect of Estrogen on Mental and Social Functioning in Girls With Turners Syndrome
|
View
|
| NCT00004268 |
|
Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
|
View
|
| NCT00004266 |
|
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
|
View
|
| NCT00004265 |
|
Paclitaxel in Treating Patients With Recurrent or Refractory Non-small Cell Lung Cancer
|
View
|
| NCT00004264 |
|
Docetaxel Cisplatin and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
|
View
|
| NCT00004263 |
|
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
|
View
|
| NCT00004262 |
|
Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
|
View
|
| NCT00004261 |
|
EF5 Prior to Surgery or Biopsy in Patients With Breast Prostate or Cervical Cancer or High Grade Soft Tissue Sarcoma
|
View
|
| NCT00004260 |
|
Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkins Lymphoma
|
View
|
| NCT00004259 |
|
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
View
|
| NCT00004258 |
|
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer
|
View
|
| NCT00004257 |
|
Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer
|
View
|
| NCT00004256 |
|
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
|
View
|
| NCT00004255 |
|
Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
|
View
|
| NCT00004254 |
|
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
|
View
|
| NCT00004253 |
|
Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
|
View
|
| NCT00004252 |
|
Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
|
View
|
| NCT00004251 |
|
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
|
View
|
| NCT00004250 |
|
Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery
|
View
|
| NCT00004249 |
|
Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy
|
View
|
| NCT00004248 |
|
Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
|
View
|
| NCT00004246 |
|
Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth Pharynx or Larynx
|
View
|
| NCT00004245 |
|
Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome Acute Myelogenous Leukemia or Chronic Lymphocytic Leukemia
|
View
|
| NCT00004244 |
|
Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma
|
View
|
| NCT00004243 |
|
Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
|
View
|
| NCT00004242 |
|
Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
|
View
|
| NCT00004241 |
|
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer Malignant Lymphoma or Sarcoma
|
View
|
| NCT00004239 |
|
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
|
View
|
| NCT00004238 |
|
10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
|
View
|
| NCT00004237 |
|
Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer
|
View
|
| NCT00004236 |
|
Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
|
View
|
| NCT00004235 |
|
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach
|
View
|
| NCT00004234 |
|
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth Pharynx or Larynx
|
View
|
| NCT00004233 |
|
S9915 Triacetyluridine Fluorouracil and Leucovorin in Treating Patients With Unresectable Locally Advanced or Metastatic Cancer of the Esophagus or Stomach
|
View
|
| NCT00004232 |
|
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
|
View
|
| NCT00004231 |
|
Combination Chemotherapy Bone Marrow or Peripheral Stem Cell Transplantation andor Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
|
View
|
| NCT00004230 |
|
Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation
|
View
|
| NCT00004229 |
|
Endostatin in Treating Patients With Advanced Solid Tumors
|
View
|
| NCT00004228 |
|
Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
|
View
|
| NCT00004227 |
|
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx Hypopharynx or Larynx
|
View
|
| NCT00004226 |
|
Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
|
View
|
| NCT00004225 |
|
Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
|
View
|
| NCT00004224 |
|
Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma
|
View
|
| NCT00004223 |
|
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
|
View
|
| NCT00004221 |
|
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer
|
View
|
| NCT00004220 |
|
Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
|
View
|
| NCT00004219 |
|
Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma
|
View
|
| NCT00004218 |
|
Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
|
View
|
| NCT00004217 |
|
S9918 PSC 833 Daunorubicin and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
|
View
|
| NCT00004216 |
|
VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy
|
View
|
| NCT00004215 |
|
Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
|
View
|
| NCT00004213 |
|
3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
|
View
|
| NCT00004212 |
|
DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
|
View
|
| NCT00004211 |
|
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
|
View
|
| NCT00004210 |
|
Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer
|
View
|
| NCT00004209 |
|
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
|
View
|
| NCT00004208 |
|
Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
|
View
|
| NCT00004207 |
|
Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
|
View
|
| NCT00004206 |
|
Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer
|
View
|
| NCT00004205 |
|
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
|
View
|
| NCT00004204 |
|
Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
|
View
|
| NCT00004203 |
|
Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
|
View
|
| NCT00004202 |
|
Combination Chemotherapy Radiation Therapy and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer
|
View
|
| NCT00004201 |
|
Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB Stage IV or Recurrent Non-small Cell Lung Cancer
|
View
|
| NCT00004200 |
|
Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
View
|
| NCT00004199 |
|
Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer
|
View
|
| NCT00004198 |
|
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkins Lymphoma
|
View
|
| NCT00004197 |
|
Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkins Lymphoma
|
View
|
| NCT00004196 |
|
Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis
|
View
|
| NCT00004195 |
|
Eniluracil and Surgery in Treating Patients With Primary or Metastatic Colorectal Cancer
|
View
|
| NCT00004194 |
|
Fludarabine in Treating Patients With Steroid-Resistant Chronic Graft- Versus-Host Disease
|
View
|
| NCT00004193 |
|
ISIS 2503 in Treating Patients With Metastatic andor Locally Recurrent Colorectal Cancer
|
View
|
| NCT00004192 |
|
Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkins Lymphoma
|
View
|
| NCT00004190 |
|
Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer
|
View
|
| NCT00004189 |
|
Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer
|
View
|
| NCT00004188 |
|
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
|
View
|
| NCT00004187 |
|
Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
|
View
|
| NCT00004186 |
|
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
|
View
|
| NCT00004184 |
|
Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma
|
View
|
| NCT00004183 |
|
Capecitabine in Treating Patients With Malignant Mesothelioma
|
View
|
| NCT00004182 |
|
Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer
|
View
|
| NCT00004181 |
|
Bone Marrow Transplantation in Treating Patients With Multiple Myeloma Chronic Phase Chronic Myelogenous Leukemia or Agnogenic Myeloid Metaplasia
|
View
|
| NCT00004180 |
|
Rosiglitazone in Treating Patients With Liposarcoma
|
View
|
| NCT00004179 |
|
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkins Lymphoma
|
View
|
| NCT00004178 |
|
Gene Therapy in Treating Patients With Cancer
|
View
|
| NCT00004177 |
|
Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer
|
View
|
| NCT00004176 |
|
Amifostine Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
|
View
|
| NCT00004175 |
|
Docetaxel Doxorubicin and Cyclophosphamide in Treating Women With Stage III Breast Cancer
|
View
|
| NCT00004174 |
|
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
|
View
|
| NCT00004173 |
|
Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
|
View
|
| NCT00004172 |
|
Chemotherapy Filgrastim and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
|
View
|
| NCT00004171 |
|
Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkins Disease or Non-Hodgkins Lymphoma
|
View
|
| NCT00004169 |
|
Chemotherapy Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkins Disease
|
View
|
| NCT00004166 |
|
Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
|
View
|
| NCT00004165 |
|
Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
|
View
|
| NCT00004164 |
|
Combination Chemotherapy in Treating Patients With Stage IIB Stage III or Stage IV Cancer of the Nasopharynx
|
View
|
| NCT00004163 |
|
Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
|
View
|
| NCT00004162 |
|
Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkins Lymphoma
|
View
|
| NCT00004161 |
|
Fenretinide in Treating Patients With Leukoplakia of the Mouth
|
View
|
| NCT00004160 |
|
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
|
View
|
| NCT00004159 |
|
Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor
|
View
|
| NCT00004158 |
|
Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
|
View
|
| NCT00004157 |
|
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkins Lymphoma Hodgkins Disease Breast Cancer or Other Solid Tumors
|
View
|
| NCT00004156 |
|
Vaccine Therapy in Treating Patients With Breast Cancer
|
View
|
| NCT00004154 |
|
Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer
|
View
|
| NCT00004153 |
|
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
|
View
|
| NCT00004152 |
|
PET and CT Scans to Evaluate Patients With Stage III or Stage IV Melanoma
|
View
|
| NCT00004151 |
|
Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer
|
View
|
| NCT00004150 |
|
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
|
View
|
| NCT00004149 |
|
Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy
|
View
|
| NCT00004148 |
|
Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma
|
View
|
| NCT00004147 |
|
COL-3 in Treating Patients With Progressive or Recurrent Brain Tumors
|
View
|
| NCT00004146 |
|
Carboxyamidotriazole RT in Treating Patients Newly Diagnosed Supratentorial GBM
|
View
|
| NCT00004145 |
|
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
|
View
|
| NCT00004144 |
|
Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer
|
View
|
| NCT00004143 |
|
Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies Bone Marrow Failure Syndromes
|
View
|
| NCT00004142 |
|
Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
|
View
|
| NCT00004141 |
|
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma
|
View
|
| NCT00004139 |
|
Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
|
View
|
| NCT00004138 |
|
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
|
View
|
| NCT00004137 |
|
S9914 Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer
|
View
|
| NCT00004136 |
|
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
|
View
|
| NCT00004135 |
|
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer
|
View
|
| NCT00004132 |
|
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
|
View
|
| NCT00004129 |
|
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
|
View
|
| NCT00004128 |
|
Combination Chemotherapy Interleukin-2 and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
|
View
|
| NCT00004127 |
|
Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
|
View
|
| NCT00004126 |
|
Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer
|
View
|
| NCT00004125 |
|
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
|
View
|
| NCT00004124 |
|
S9921 Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
|
View
|
| NCT00004123 |
|
Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma
|
View
|
| NCT00004122 |
|
BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
|
View
|
| NCT00004115 |
|
Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
|
View
|
| NCT00004114 |
|
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
|
View
|
| NCT00004113 |
|
Temozolomide in Treating Patients With Recurrent Malignant Glioma
|
View
|
| NCT00004112 |
|
Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkins Lymphoma
|
View
|
| NCT00004110 |
|
Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
|
View
|
| NCT00004109 |
|
Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma
|
View
|
| NCT00004108 |
|
DX-8951f in Treating Patients With Liver Cancer
|
View
|
| NCT00004107 |
|
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstroms Macroglobulinemia
|
View
|
| NCT00004106 |
|
Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
|
View
|
| NCT00004105 |
|
Combination Chemotherapy in Treating Patients With Advanced Cancer
|
View
|
| NCT00004104 |
|
Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma
|
View
|
| NCT00004103 |
|
Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
|
View
|
| NCT00004102 |
|
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
|
View
|
| NCT00004101 |
|
Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkins Lymphoma
|
View
|
| NCT00004100 |
|
Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
|
View
|
| NCT00004099 |
|
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
|
View
|
| NCT00004097 |
|
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced andor Recurrent Head and Neck Cancer
|
View
|
| NCT00004096 |
|
Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
|
View
|
| NCT00004095 |
|
Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
|
View
|
| NCT00004094 |
|
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth Pharynx or Larynx
|
View
|
| NCT00004093 |
|
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
|
View
|
| NCT00004092 |
|
Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
|
View
|
| NCT00004091 |
|
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
|
View
|
| NCT00004090 |
|
Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors
|
View
|
| NCT00004089 |
|
Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
|
View
|
| NCT00004088 |
|
Combination Chemo Peripheral Stem Cell Transplant Biological Therapy Pamidronate and Thalidomide for Multiple Myeloma
|
View
|
| NCT00004087 |
|
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
|
View
|
| NCT00004086 |
|
Radiolabeled Monoclonal Antibody Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
|
View
|
| NCT00004085 |
|
Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
|
View
|
| NCT00004084 |
|
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
|
View
|
| NCT00004083 |
|
Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
|
View
|
| NCT00004082 |
|
Combination Chemotherapy in Treating Patients With Previously Untreated Newly Diagnosed Epithelial Tumors
|
View
|
| NCT00004081 |
|
Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
|
View
|
| NCT00004080 |
|
Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors
|
View
|
| NCT00004079 |
|
Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid Tumors
|
View
|
| NCT00004078 |
|
Irinotecan in Treating Children With Refractory Solid Tumors
|
View
|
| NCT00004077 |
|
Paclitaxel Ifosfamide and Cisplatin in Treating Patients With Metastatic Testicular Cancer
|
View
|
| NCT00004076 |
|
PNU 166148 in Treating Patients With Metastatic Solid Tumors
|
View
|
| NCT00004075 |
|
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
|
View
|
| NCT00004074 |
|
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2Neu
|
View
|
| NCT00004073 |
|
Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
|
View
|
| NCT00004072 |
|
O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma
|
View
|
| NCT00004071 |
|
Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer
|
View
|
| NCT00004070 |
|
Gene Therapy in Treating Patients With Unresectable Recurrent or Refractory Head and Neck Cancer
|
View
|
| NCT00004068 |
|
Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor
|
View
|
| NCT00004067 |
|
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
|
View
|
| NCT00004066 |
|
Gemcitabine Docetaxel and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
|
View
|
| NCT00004065 |
|
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
|
View
|
| NCT00004064 |
|
Monoclonal Antibody Therapy in Treating Patients With Ovarian Fallopian Tube or Peritoneal Cancer
|
View
|
| NCT00004063 |
|
Cisplatin Gemcitabine Interferon Alfa and Hyperthermia in Treating Patients With Advanced Cancer
|
View
|
| NCT00004062 |
|
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
|
View
|
| NCT00004061 |
|
Biological Therapy in Treating Patients Undergoing Radiation Therapy Chemotherapy and Peripheral Stem Cell Transplantation for Hematologic Cancer
|
View
|
| NCT00004060 |
|
Chemotherapy in Treating Patients With Recurrent Metastatic or Unresectable Ovarian Fallopian Tube or Peritoneal Cancer
|
View
|
| NCT00004059 |
|
Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors
|
View
|
| NCT00004058 |
|
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
|
View
|
| NCT00004057 |
|
Paclitaxel Plus L-778123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas
|
View
|
| NCT00004056 |
|
Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
|
View
|
| NCT00004055 |
|
Topotecan Paclitaxel and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
|
View
|
| NCT00004054 |
|
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
|
View
|
| NCT00004052 |
|
Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia
|
View
|
